Layolis Fe

Actavis Pharma, Inc.🇺🇸 United States

FDA Page

Effective Date: Mar 22, 2024
Approval ID: c0db84ca-b8d4-4ed2-b2f6-19347283146e
Products: 1 registered
Version: 9

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use LAYOLIS Fe safely and effectively. See full prescribing information for Fe. Fe (norethindrone and ethinyl estradiol chewable tablets and ferrous fumarate chewable tablets) Initial U.S. Approval: 1974

Quick Stats

Total Products1

Labelers2

Label Sections36

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.